Fender's free guitar-focused Studio recording app/amp sim (Studio) is handy indeed for quick takes and practice, though it ...

Laffont favors tech companies in his Coatue Management fund, and has bought shares of AI giants recently. These players should benefit from the need for AI capacity in the coming years. One of these ...

Shares of the global tech company jumped 9.30%, rising by $4.46 to finish at $52.40 during regular trading on Wednesday. This marks the third day in a row the stock has been on the rise. The stock ...

A year ago, Oracle cofounder and chairman Larry Ellison described a future where everyone, including law enforcement, will face regular surveillance as daily life is documented seemingly nonstop. At ...

Aiden Fletcher isn’t ashamed to admit it. There were more than a few times during his freshman season at Westminster when the upperclassmen had to reposition him on the field. But that was the point.

According to a recent study conducted by the global consulting firm, EY, 97% of respondents reported that it is important for companies to act with integrity. Many companies tout integrity as a core ...

A Catholic priest returned to work at his suburban Cincinnati parishes Wednesday after an investigation determined he did not use a church computer to access pornography. Officials at the Archdiocese ...

Despite missing Thursday night’s game against the Dolphins due to an injury, Buffalo Bills LB Matt Milano got some on Friday courtesy of Bills head coach Sean McDermott. Milano was ruled out of the ...

A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability that could lead to new therapies and bring the world closer to a ...

Aditi Verma receives research funding from the U.S. Department of Energy. She is a board member for the Good Energy Collective and serves on various expert working groups of the OECD Nuclear Energy ...

Biosafety hawks were initially optimistic that the incoming second Trump administration would at last place binding constraints on so-called "dangerous gain-of-function" research, in which pathogens ...